Baudax Bio to Present at the Oppenheimer 32nd Annual Healthcare Conference

Rhea-AI Summary

Baudax Bio, a pharmaceutical company focused on acute care products, announced that CEO Gerri Henwood will present at the Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022, at 2:40 p.m. ET. A live webcast of the presentation will be available on the company's investors page, and a replay will be accessible for 30 days post-event.

Baudax Bio is known for ANJESO, the first 24-hour intravenous COX-2 preferential NSAID for managing moderate to severe pain, alongside a pipeline of innovative pharmaceutical products.

MALVERN, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the Oppenheimer 32^nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 2:40 p.m. Eastern Time.

A live webcast of the presentation will be available on the “Events” page within the investors section of the Baudax Bio website at https://www.baudaxbio.com/news-and-investors. A replay will be available on the Baudax Bio website for a period of 30 days following the event.

About Baudax Bio

Baudax Bio is a pharmaceutical company focused on commercializing and developing innovative products for acute care settings. ANJESO is the first and only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain. In addition to ANJESO, Baudax Bio has a pipeline of other innovative pharmaceutical assets including two novel neuromuscular blocking agents (NMBs) and a proprietary chemical reversal agent specific to these NMBs. For more information, please visit www.baudaxbio.com.

CONTACT:

Investor Relations Contact:

Argot Partners
Sam Martin / Kaela Ilami
(212) 600-1902
baudaxbio@argotpartners.com

Media Contact:

Argot Partners
David Rosen
(212) 600-1902
david.rosen@argotpartners.com

FAQ

When is Baudax Bio's presentation at the Oppenheimer Healthcare Conference?

Baudax Bio's presentation will take place on March 15, 2022, at 2:40 p.m. Eastern Time.

Where can I watch the Baudax Bio presentation live?

The live webcast of Baudax Bio's presentation can be found on the company's investors page.

What is ANJESO by Baudax Bio?

ANJESO is the first and only 24-hour intravenous COX-2 preferential NSAID for managing moderate to severe pain.

Will there be a replay of the Baudax Bio presentation?

Yes, a replay of the presentation will be available on the Baudax Bio website for 30 days after the event.

What is the stock symbol of Baudax Bio?

The stock symbol for Baudax Bio is BXRX.